AJP - Lung Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 293: L583-L590, 2007. First published June 22, 2007; doi:10.1152/ajplung.00321.2006
1040-0605/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Video
Right arrow All Versions of this Article:
293/3/L583    most recent
00321.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by White, R. J.
Right arrow Articles by Taubman, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, R. J.
Right arrow Articles by Taubman, M. B.

EDITORIAL FOCUS

Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension

R. James White,1,2 David F. Meoli,1,2 Robert F. Swarthout,1,2 Dara Y. Kallop,1,2 Irfan I. Galaria,2 Jennifer L. Harvey,2 Christine M. Miller,2 Burns C. Blaxall,2 Carla M. Hall,3 Richard A. Pierce,3 Carlyne D. Cool,4 and Mark B. Taubman2

1Division of Pulmonary and Critical Care Medicine and 2Cardiovascular Research Institute, University of Rochester, Rochester, New York; 3Division of Pulmonary and Critical Care, Washington University School of Medicine, Saint Louis, Missouri; and 4Department of Pathology, National Jewish Center, Denver, Colorado

Submitted 20 August 2006 ; accepted in final form 12 June 2007

Severe pulmonary arterial hypertension (PAH) occurs in idiopathic form and in association with diverse diseases. The pathological hallmarks are distal smooth muscle hypertrophy, obliteration of small pulmonary arteriole lumens, and disorganized cellular proliferation in plexiform lesions. In situ thrombosis is also observed. A detailed understanding of the disease progression has been hampered by the absence of an animal model bearing all the pathological features of human disease. To create a model with these characteristics, we gave young (200-g) rats monocrotaline 1 wk following left pneumonectomy; controls with vehicle treatment or sham operation were also studied. In experimental rats, pulmonary arteries had distal smooth muscle hypertrophy and proliferative perivascular lesions. The lesions had a plexiform appearance, occurred early in disease development, and were composed of cells expressing endothelial antigens. Three-dimensional microangiography revealed severe vascular pruning and disorganized vascular networks. We found that expression of tissue factor (TF), the membrane glycoprotein that initiates coagulation, facilitates angiogenesis, and mediates arterial injury in the systemic circulation, was increased in the pulmonary arterioles and plexiform-like lesions of the rats. TF was also heavily expressed in the vessels and plexiform lesions of humans with pulmonary arterial hypertension. We conclude that plexiform-like lesions can be reproduced in rats, and this model will facilitate experiments to address controversies about the role of these lesions in PAH. Increased TF expression may contribute to the prothrombotic diathesis and vascular cell proliferation typical of human disease.

vascular biology; monocrotaline; neointimal formation; angiography



Address for reprint requests and other correspondence: R. J. White, Division of Pulmonary and Critical Care Medicine, Univ. of Rochester, 601 Elmwood Ave., Box 692, Rochester, NY (e-mail: Jim_White{at}urmc.rochester.edu)




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. A. Sovershaev, E. M. Egorina, J.-B. Hansen, B. Osterud, P. Pacher, J.-P. Stasch, and O. V. Evgenov
Soluble Guanylate Cyclase Agonists Inhibit Expression and Procoagulant Activity of Tissue Factor
Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1578 - 1586.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Lee, R. Reich, F. Xu, and P. B. Sehgal
Golgi, trafficking, and mitosis dysfunctions in pulmonary arterial endothelial cells exposed to monocrotaline pyrrole and NO scavenging
Am J Physiol Lung Cell Mol Physiol, October 1, 2009; 297(4): L715 - L728.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. B. Sehgal, S. Mukhopadhyay, K. Patel, F. Xu, S. Almodovar, R. M. Tuder, and S. C. Flores
Golgi dysfunction is a common feature in idiopathic human pulmonary hypertension and vascular lesions in SHIV-nef-infected macaques
Am J Physiol Lung Cell Mol Physiol, October 1, 2009; 297(4): L729 - L737.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. F. Meoli and R. J. White
Thrombin induces fibronectin-specific migration of pulmonary microvascular endothelial cells: requirement of calcium/calmodulin-dependent protein kinase II
Am J Physiol Lung Cell Mol Physiol, October 1, 2009; 297(4): L706 - L714.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. E. Roberts, M. B. Fallon, M. J. Krowka, R. S. Brown, J. F. Trotter, I. Peter, H. Tighiouart, J. A. Knowles, D. Rabinowitz, R. L. Benza, et al.
Genetic Risk Factors for Portopulmonary Hypertension in Patients with Advanced Liver Disease
Am. J. Respir. Crit. Care Med., May 1, 2009; 179(9): 835 - 842.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Nozik-Grayck, H. B. Suliman, S. Majka, J. Albietz, Z. Van Rheen, K. Roush, and K. R. Stenmark
Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling
Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L422 - L430.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. Homma, T. Nagaoka, V. Karoor, M. Imamura, L. Taraseviciene-Stewart, L. A. Walker, K. A. Fagan, I. F. McMurtry, and M. Oka
Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone
Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L71 - L78.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.